Neutropenia

Granix is a human granulocyte factor produced in a bioreactor using recombinant DNA technology.

The FDA is changing dispensing requirements for the schizophrenia drug clozapine (Clozaril) to address safety concerns about severe neutropenia.

The first biosimilar to receive FDA approval is now available the United States.

Chemotherapy-induced neutropenia (CIN) is a common adverse occurrence in patients treated for solid tumors.

Specialty and community pharmacies more involved in cancer treatment.

After years of debate and regulatory hurdles, a milestone was achieved today when the FDA approved the first biosimilar in the United States.

Teva's Granix Injection has been approved by the FDA for self-administration by patients and caregivers.